Pages that link to "Q51814947"

The following pages link to Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer. (Q51814947):

Displaying 31 items.

• Recent advancements in erythrocytes, platelets, and albumin as delivery systems (Q26747764) (← links)
• Albumin-bound paclitaxel in solid tumors: clinical development and future directions (Q26798674) (← links)
• Microtubule-binding agents: a dynamic field of cancer therapeutics (Q27690249) (← links)
• Clinical Translation of Nanomedicine. (Q30355939) (← links)
• Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics (Q30421664) (← links)
• A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma (Q33435722) (← links)
• Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions. (Q33442096) (← links)
• Clinical trials and progress with paclitaxel in ovarian cancer (Q34510070) (← links)
• Retrovirus-mediated multidrug resistance gene (MDR1) overexpression inhibits chemotherapy-induced toxicity of granulosa cells (Q34726096) (← links)
• A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study (Q35013760) (← links)
• Src family kinases and paclitaxel sensitivity (Q35214722) (← links)
• Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer. (Q36359684) (← links)
• Current status of bevacizumab in advanced ovarian cancer (Q37048186) (← links)
• Harnessing competing endocytic pathways for overcoming the tumor-blood barrier: magnetic resonance imaging and near-infrared imaging of bifunctional contrast media (Q37314509) (← links)
• Taxanes: their impact on gynecologic malignancy (Q37692801) (← links)
• Combination therapy of albumin-bound Paclitaxel and Carboplatin as first line therapy in a patient with ovarian cancer (Q37718771) (← links)
• Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer (Q37822160) (← links)
• Albumin-Bound Paclitaxel: The Benefit of This New Formulation in the Treatment of Various Cancers (Q37875561) (← links)
• Harnessing the potential of lipid-based nanomedicines for type-specific ovarian cancer treatments. (Q38205584) (← links)
• Incidence and risk of peripheral neuropathy with nab-paclitaxel in patients with cancer: a meta-analysis (Q38946259) (← links)
• Antibody-drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment. (Q39030222) (← links)
• Paclitaxel-loaded polyester nanoparticles prepared by spray-drying technology: in vitro bioactivity evaluation. (Q39511265) (← links)
• Toxicological study and efficacy of blank and paclitaxel-loaded lipid nanocapsules after i.v. administration in mice (Q39754951) (← links)
• Efficacy and safety of nab-paclitaxel combined with carboplatin in Chinese patients with melanoma (Q41460534) (← links)
• Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer. (Q41897007) (← links)
• Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma (Q46170735) (← links)
• Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotheprapy to treat patients with peritoneal carcinomatosis. (Q47165034) (← links)
• Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety. (Q53008476) (← links)
• Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents. (Q53598744) (← links)
• Research progresses of albumin-bound paclitaxel in the treatment of non-small cell lung cancer (Q55504680) (← links)
• Imaging and therapy of ovarian cancer: clinical application of nanoparticles and future perspectives (Q57174233) (← links)